Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Datopotamab deruxtecan

   Daiichi Sankyo

   Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

   phase 2 · small molecule · active

   1 trial →

2. Datopotamab deruxtecan

   AstraZeneca AB

   Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy

   phase 2 · small molecule · active

   1 trial →

3. Dazostinag

   Takeda

   Solid Neoplasms

   phase 2 · small molecule · completed

   1 trial →

4. Debio 4228, Debio 4228

   Alphapharm Pty Ltd

   advanced prostate cancer

   phase 2 · small molecule · active

   1 trial →

5. Decitabine

   Teva Pharma GmbH

   Acute Myeloid Leukemia

   phase 2 · small molecule · completed

   1 trial →

6. Decitabine

   Shanghai Tong Ren Hospital

   Acute Myeloid Leukemia

   phase 2 · small molecule · active

   1 trial →

7. Decitabine

   The University of Hong Kong

   Acute Myeloid Leukemia

   phase 2 · small molecule · active

   1 trial →

8. Decitabine

   Karyopharm Therapeutics Inc

   Ovarian Cancer

   phase 2 · small molecule · active

   1 trial →

9. Decitabine

   CATALYST PHARMACEUTICALS, INC.

   Acute Myeloid Leukemia

   phase 2 · small molecule · active

   1 trial →

10. Decoy20

    BRIGHT MINDS BIOSCIENCES INC.

    Solid Tumor, Adult

    phase 2 · small molecule · active

    1 trial →

11. Degarelix

    Regeneron UK Limited

    Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

12. Demcizumab

    Mereo BioPharma Group plc

    Pancreatic Cancer

    phase 2 · small molecule · completed

    2 trials →

13. Dendritic Cell Vaccination

    Quantum Biopharma

    Breast Cancer

    phase 2 · mab · active

    1 trial →

14. Dendritic Cell/Tumor Fusion Vaccine

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · mab · terminated

    1 trial →

15. Denosumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    phase 2 · small molecule · active

    1 trial →

16. Dental stent

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma

    phase 2 · other · active

    1 trial →

17. Derazantinib

    Basilea Pharmaceutica

    Gastric Adenocarcinoma

    phase 2 · small molecule · terminated

    1 trial →

18. Dexamethasone

    Kura Oncology

    Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

19. Dexamethasone

    The First People's Hospital of Lianyungang

    Precursor B-Cell Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

20. Dietary

    The University of Hong Kong

    Colorectal Cancer

    phase 2 · other · active

    1 trial →

21. Disitamab Vedotin

    The First People's Hospital of Lianyungang

    HER2-positive Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

22. Disitamab Vedotin

    Pfizer Australia Pty Ltd

    HER2 Expressing Advanced Breast Cancer

    phase 2 · small molecule · active

    1 trial →

23. Disitamab Vedotin (RC48)

    The First People's Hospital of Lianyungang

    Upper Tract Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

24. Docetaxel

    Takeda

    Non-small Cell Lung Cancer

    phase 2 · small molecule · terminated

    1 trial →

25. Docetaxel

    Hospital Authority, Hong Kong

    Non Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

26. Docetaxel

    Karyopharm Therapeutics Inc

    Recurrent Squamous Cell Lung Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

27. Docetaxel

    BRIGHT MINDS BIOSCIENCES INC.

    Prostatic Neoplasms

    phase 2 · small molecule · completed

    1 trial →

28. Docetaxel

    Merck KGaA, Darmstadt, Germany

    Castration-Resistant Prostatic Cancer

    phase 2 · small molecule · active

    1 trial →

29. Docetaxel + Sunitinib

    Samsung Bioepis NL B.V.

    Advanced Gastric Cancer

    phase 2 · small molecule · completed

    1 trial →

30. Docetaxel, Reolysin and Prednisone

    ONCOLYTICS BIOTECH INC

    Prostate Cancer

    phase 2 · small molecule · completed

    1 trial →

31. Dociparstat sodium

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 · small molecule · completed

    1 trial →

32. Domvanalimab

    Arcus Biosciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

33. Domvanalimab

    Arcus Biosciences

    Advanced Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

34. Domvanalimab

    Arcus Biosciences

    Non Small Cell Lung Cancer

    phase 2 · small molecule · active

    2 trials →

35. Donafenib + Envafolimab

    Anhui Provincial Hospital

    Hepatocellular Carcinoma

    phase 2 · small molecule · active

    1 trial →

36. Dopacis 90 MBq/ml oplossing voor injectie

    CERO THERAPEUTICS HOLDINGS, INC.

    patients with newly discovered brain metastases (non-small cell lung cancer, breast cancer or melanoma) measuring more than 5 mm and explored on MRI

    phase 2 · small molecule · active

    1 trial →

37. Dordaviprone (ONC201)

    Jazz Pharmaceuticals Ireland Limited

    Endometrial Cancer Recurrent

    phase 2 · small molecule · terminated

    1 trial →

38. Dose Escalation Doublet: Combination of NKTR-214 + nivolumab

    Nektar Therapeutics UK Limited

    Melanoma

    phase 2 · small molecule · completed

    1 trial →

39. Dostarlimab

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Ovarian Clear Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

40. Doxorubicin Hydrochloride

    Children's Hospital of Fudan University

    Childhood Renal Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

41. Doxorubicin liposome

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

42. Doxycycline

    United Therapeutics Europe Ltd

    Advanced Malignant Neoplasm

    phase 2 · small molecule · completed

    1 trial →

43. Dragon Boat Training

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · other · active

    1 trial →

44. Drug: B10 L-BPA Injection

    Heron Therapeutics

    Head and Neck Cancer

    phase 2 · small molecule · active

    1 trial →

45. Drug: GC4419

    Galera Therapeutics

    Head and Neck Cancer

    phase 2 · small molecule · completed

    1 trial →

46. Drug: Pembrolizumab

    Hospital Authority, Hong Kong

    Clear-cell Metastatic Renal Cell Carcinoma

    phase 2 · other · active

    1 trial →

47. Dupilumab

    Coherus Oncology

    Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

48. Dupilumab

    Regeneron UK Limited

    Prostate Cancer

    phase 2 · small molecule · terminated

    1 trial →

Frequently asked questions